Global Health Outcomes | The Global Team

The Global Health Outcomes,Inc. team is comprised of management and advisory board members with the experience necessary to direct the company’s day-to-day operations and growth strategy, while continually looking for innovative ways to meet the needs of clients and investors.

Javaid Zafar

Javaid Zafar is the President and Chief Strategy Officer of Global Health Outcomes, Inc. His professional experience includes working for Accenture Consulting and several technology start-ups, providing consulting services in the Healthcare, Retail, and Government sectors. Javaid also possesses significant experience in designing and delivering Enterprise Resource Planning (ERP) and Customer Relationship Management (CRM) solutions to mid-size and large organizations. From 2000 to 2003, Javaid served in many product / project development roles with firms in Silicon Valley. His recent activities have centered on entrepreneurship ventures in the Chicago and surrounding suburbs, where he has started and continues to lead several retail and insurance brokerage businesses. Javaid is a graduate of Cornell University.

Efthimios Parasidis

Efthimios Parasidis is Vice President and Chief Legal Officer of Global Health Outcomes, Inc. His experience spans the private sector, working for corporate law firms in New York as an Intellectual Property attorney, and public service, as an Assistant Attorney General for the State of New York. He is a professor at the Center for Health Law Studies at Saint Louis University, which is consistently ranked as the premier health law program in the United States. Mr. Parasidis focuses his research in biotechnology law, has conducted health research in Greece as a Fulbright Fellow, and serves as a consultant to the American College of Physicians. He earned his Juris Doctorate and Master's in Bioethics from the University of Pennsylvania, and was recently named a Health Law Scholar by the American Society of Law, Medicine & Ethics.

Michael Frank is an attorney in south Florida, who has extensive legal and business experience. Michael is an entrepreneurial spirit with small business experience where he developed sales and business development skills. He is also an avid volunteer, having worked with American Cancer Society, Sickle Cell Disease Association of America, Cooley's Anemia Foundation, and Special Olympics. Michael is a graduate of Syracuse University Law School.

Dr. Petratos's pharmaceutical career includes experience in the Research, Development & Medical Affairs Divisions, specifically working for the past seven years on the development and commercialization of molecules in oncology, transplant, multiple sclerosis and rheumatoid arthritis. He was previously the Director of Clinical Decision Support, where he oversaw data-driven applications of clinical information management in the areas of protocol design, graphical medical review, analysis, reporting and publications which supported the discovery, approval, and promotion of medicines for the benefit of patients worldwide. Dr. Petratos helped to design the strategy and implementation of Patient Reported Outcomes and Quality of Life claims for Oncology and Neurologic medicines. Prior to pharmaceuticals he conducted clinical research at Intermountain Healthcare and the University of Utah Health Sciences Center as part of a National Institutes of Health Fellowship with the National Library of Medicine in Biomedical Informatics. There he learned and applied advanced methods of clinical information management to improve patient safety and measure outcomes related to adverse drug event detection capabilities for Oncology, Pain Management, and Antibiotic drugs.

Dr. Petratos was born and raised in New York City and obtained his bachelor’s degree in Biology from Cornell University. After college he joined a non-profit organization managing HIV/AIDS patients in the American Indian community of New York. He then received his Doctor of Medicine degree from Howard University in Washington, D.C., and obtained a Master’s in Health Service Administration and Medical Informatics from the University of Utah. He heads the Alumni Network for the Biomedical Informatics Department of the University of Utah, and is also active in the Hellenic Medical Society of New York and the Global Hellenic Medical Network. He has spoken at numerous occasions, including the Drug Information Association, the American Health Information Management Association, the Healthcare Information Management Systems Society, and the Graduate Seminar of the University of Utah.

Caleb has extensive experience in the pharmaceutical industry. Caleb worked as a public policy executive at two-major global bio-pharmaceutical companies - Hoffmann-La Roche and Pfizer Inc.,respectively. Caleb's federal policy experience includes serving as a Special Assistant at the U.S. Centers for Medicare and Medicaid Services (CMS) in Washington, DC where he worked on implementation of the Medicare Modernization Act. Caleb serves on the health advisory board of the Executive Council, and is on the board of directors of the Primary Care Development Corporation, the Massachusetts Association for Mental Health, and Global Health Outcomes Inc. Caleb is also affiliated with the government relations/policy firm of HillCo Health, based in Washington, D.C.

Stuart O. Schweitzer, Ph.D.,Professor of Health Services, UCLA School of Public Health.

Stuart O. Schweitzer is Professor of Health Services. He teaches courses in health economics, health system organization and financing, pharmaceuticals, and comparative health systems. Professor Schweitzer earned his Ph.D. in economics from the University of California, Berkeley. He has taught at Wayne State University and Georgetown University, as well as having been on the research staff of The Urban Institute and the National Institutes of Health. He served on President Carter's Commission for a National Agenda for the Eighties, and has held visiting appointments at Oxford University, CREDES (Paris), ESSEC (Paris), the University of Ferrara (Italy), and the Shanghai Medical University. His research interests are in the areas of health policy, especially as they pertain to pharmaceuticals, gerontology, and the financing of health care. Dr. Schweitzer directed a 6-year assessment of health screening and promotion for the elderly, financed by the Health Care Financing Administration. He co-directs the UCLA Research Program in Pharmaceutical Economics and Policy, with Professors William Comanor and Michael Intriligator.

Malcolm Bohm is an expert in the application of healthcare data to R&D strategies. Mr Bohm has a unique breadth of clinical research experience in the pharmaceutical industry and a proven track record throughout all phases of drug development. Mr Bohm joined the pharmaceutical industry in 1993 serving in increasingly senior positions at major pharmaceutical companies including Astra, Pfizer and Novartis. Most recently, Mr Bohm served as the Executive Director of Global Data Sciences and Reporting & Americas Clinical Operations, at Aspreva Pharmaceuticals. Several of the projects he led resulted in product launches including drugs for cardiovascular disease, urology and women's health. Mr Bohm was educated in Great Britain and has a Bachelor of Science degree in Physiology and a Master of Medical Sciences degree in Renal Physiology and Pharmacology and has advanced training in analytical data modeling.

Mr. Powers worked for more than a decade in the public sector including positions as the Administrator of the $8 billion Illinois Medicaid Program and the Division Chief for Social Services and Economic Development at the Illinois Bureau of the Budget. Illinois obtained the nation's first Pharmacy Plus Medicaid waiver and substantially increased enrollments in Medicaid and the Children's Health Insurance Program while Mr. Powers was the Medicaid Administrator. Prior to joining HMA, Mr. Powers headed his own consulting firm. Mr. Powers focuses on issues related to Medicaid, Medicare, and the uninsured and is a frequent speaker at conferences, workshops, and universities. Mr. Powers has an undergraduate degree from the University of Illinois in Urbana/Champaign.

With a background in both law and medicine to provide a unique perspective, Dr. Weintraub teaches health law courses focusing on managed care, the doctor-patient relationship, Medicare and Medicaid.

Engaged in the private practice of ophthalmology on Long Island for over 30 years, he continues to be active in the instruction of medical students, interns, and residents and is a faculty member of the Albert Einstein College of Medicine. He has authored numerous articles on glaucoma, ocular inflammation, and myopia.

A past president of the Long Island Ophthalmological Society and past chair of the Section of Ophthalmology of the Nassau Academy of Medicine, he has also served as president of the medical staff, director of ophthalmology, and member of the board of trustees of Long Island hospitals and was the founding member and president of Long Island Ophthalmic Surgery Consultants, P.C. From 1994 until 2000 he served as president of the Myopia International Research Foundation. He is a Fellow of the American College of Surgeons, a Life Member of the Medical Society of the State of New York and of the Nassau County Medical Society and a member of the Health Law Section of the New York State Bar Association and of its Committee on Ethical Issues in the Provision of Health Care.